21-46490629-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015151.4(DIP2A):āc.193A>Gā(p.Arg65Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000905 in 1,580,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015151.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIP2A | NM_015151.4 | c.193A>G | p.Arg65Gly | missense_variant | 3/38 | ENST00000417564.3 | NP_055966.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIP2A | ENST00000417564.3 | c.193A>G | p.Arg65Gly | missense_variant | 3/38 | 1 | NM_015151.4 | ENSP00000392066.2 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000101 AC: 20AN: 197462Hom.: 0 AF XY: 0.0000757 AC XY: 8AN XY: 105720
GnomAD4 exome AF: 0.0000903 AC: 129AN: 1428052Hom.: 0 Cov.: 32 AF XY: 0.0000707 AC XY: 50AN XY: 707126
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.193A>G (p.R65G) alteration is located in exon 3 (coding exon 3) of the DIP2A gene. This alteration results from a A to G substitution at nucleotide position 193, causing the arginine (R) at amino acid position 65 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at